Order Article Reprints

Tarabay A, Boileve A, Smolenschi C, Antoun L, Valery M, Fuerea A, Perret A, Burtin P, Cosconea S, Belkhodja H, et al. Precision Medicine in Pancreatic Ductal Adenocarcinoma: The Impact of Targeted Therapies on Survival of Patients Harboring Actionable Mutations. Biomedicines. 2023; 11(9):2569. https://doi.org/10.3390/biomedicines11092569

Tarabay, Anthony, Alice Boileve, Cristina Smolenschi, Leony Antoun, Marine Valery, Alina Fuerea, Audrey Perret, Pascal Burtin, Simona Cosconea, Hichem Belkhodja, and et al. 2023. "Precision Medicine in Pancreatic Ductal Adenocarcinoma: The Impact of Targeted Therapies on Survival of Patients Harboring Actionable Mutations" Biomedicines 11, no. 9: 2569. https://doi.org/10.3390/biomedicines11092569

Tarabay, A., Boileve, A., Smolenschi, C., Antoun, L., Valery, M., Fuerea, A., Perret, A., Burtin, P., Cosconea, S., Belkhodja, H., Malka, D., Boige, V., Hollebecque, A., & Ducreux, M. (2023). Precision Medicine in Pancreatic Ductal Adenocarcinoma: The Impact of Targeted Therapies on Survival of Patients Harboring Actionable Mutations. Biomedicines, 11(9), 2569. https://doi.org/10.3390/biomedicines11092569